You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: March 29, 2025

Details for Patent: 11,033,565


✉ Email this page to a colleague

« Back to Dashboard


Summary for Patent: 11,033,565
Title:Topical application of ivermectin for the treatment of dermatological conditions/afflictions
Abstract: Dermatological conditions/afflictions such as rosacea, common acne, seborrheic dermatitis, perioral dermatitis, acneform rashes, transient acantholytic dermatosis, and acne necrotica miliaris, most notably rosacea, are treated by topically applying onto the affected skin area of an individual in need of such treatment, a topical pharmaceutical composition which comprises a thus effective amount of ivermectin.
Inventor(s): Manetta; Vincent (Bordentown, NJ), Watkins; Gary R. (Piscataway, NJ)
Assignee: Galderma Holding SA (La Tour-de-Peilz, CH)
Application Number:15/625,362
Patent Claim Types:
see list of patent claims
Compound;
Patent landscape, scope, and claims:

Understanding the Scope and Claims of United States Patent 11,033,565: A Comprehensive Analysis

Introduction

Patents are a cornerstone of innovation, providing exclusive rights to inventors and companies for their intellectual property. Analyzing the scope and claims of a patent is crucial for understanding its validity, enforceability, and potential impact on the market. This article delves into the details of United States Patent 11,033,565, exploring its claims, the patent landscape, and relevant legal and practical considerations.

Patent Overview

Patent Number and Title

United States Patent 11,033,565, though not specifically detailed in the provided sources, can be analyzed using general principles and tools available for patent research.

Invention Description

To analyze the patent, one must first understand the invention it describes. This involves reading the patent specification, which includes the background of the invention, the summary of the invention, and the detailed description of the preferred embodiments.

Claims Analysis

Types of Claims

Patents typically include various types of claims: independent claims, dependent claims, and sometimes method claims or system claims. Independent claims stand alone and define the invention without reference to other claims, while dependent claims refer back to and further limit an independent claim[3].

Claim Construction

Claim construction is a critical step in determining the scope of a patent. This involves interpreting the language of the claims to understand what is covered by the patent. The Federal Circuit has established guidelines for claim construction, emphasizing the importance of understanding the claims in the context of the specification and the prosecution history of the patent[2].

Alice Test for Patent Eligibility

For patents, especially those involving software or abstract ideas, the Alice test is crucial. This test, established by the Supreme Court in Alice Corp. v. CLS Bank International, involves two steps:

  1. Determine if the claims are directed to a patent-ineligible concept: This includes abstract ideas, laws of nature, or natural phenomena.
  2. Determine if the claims contain an inventive step: If the claims are directed to a patent-ineligible concept, they must contain an inventive step that transforms the concept into a patent-eligible application[2].

Patent Landscape

Prior Art and Citations

Understanding the prior art and citations related to the patent is essential. Tools like the Common Citation Document (CCD) and the Global Dossier provided by the USPTO help in consolidating prior art cited by various patent offices, giving a comprehensive view of the patent family and related applications[4].

Competitors and Market Impact

Analyzing the patent landscape also involves identifying competitors and understanding the market impact of the patent. This can be done by searching for similar patents, identifying key players in the industry, and assessing how the patent might affect market dynamics.

Legal Considerations

Patent Litigation Trends

Recent trends in patent litigation, such as those influenced by the Leahy-Smith America Invents Act (AIA), can impact the enforcement and validity of patents. For instance, the AIA introduced changes that affected the number of defendants in a lawsuit and the use of inter partes review (IPR) proceedings[1].

Judicial Developments

Judicial developments, such as the decisions in Alice Corp. v. CLS Bank International and other Federal Circuit cases, play a significant role in shaping patent law. These decisions can affect how claims are constructed and whether they are deemed patent-eligible[2].

Practical Considerations

Patent Quality and Examination Process

The quality of the patent and the examination process are critical. The USPTO has been working to improve patent quality by linking trends in patent infringement litigation to internal data on the patent examination process. This helps in identifying potential issues early on and enhancing the overall quality of issued patents[1].

Small Claims Patent Court

There have been discussions and studies on the feasibility of a small claims patent court, which could simplify and reduce the costs associated with patent litigation for smaller entities. This could have significant practical implications for inventors and small businesses[5].

Tools and Resources for Analysis

USPTO Databases

The USPTO provides several databases and tools, such as the Patent Claims Research Dataset, which contain detailed information on claims from U.S. patents and applications. These datasets can be used to analyze claim-level statistics and document-level statistics, providing insights into patent scope and trends[3].

Public Search Facilities

The USPTO Public Search Facility and Patent and Trademark Resource Centers (PTRCs) offer access to patent and trademark information, assisting in thorough searches and analyses of patents[4].

Key Takeaways

  • Claims Construction: Understanding the language and context of the claims is crucial for determining the scope of a patent.
  • Patent Eligibility: The Alice test is essential for ensuring that patents, especially those involving abstract ideas, meet the criteria for patent eligibility.
  • Patent Landscape: Analyzing prior art, citations, and competitors helps in understanding the market impact and validity of a patent.
  • Legal and Practical Considerations: Recent legal developments and practical tools such as the USPTO databases are vital for a comprehensive analysis.
  • Improving Patent Quality: Linking trends in patent litigation to the examination process can enhance patent quality.

FAQs

Q: What is the significance of the Alice test in patent law?

A: The Alice test is a two-step process used to determine if a patent claim is directed to patent-ineligible subject matter, such as an abstract idea, and if it contains an inventive step that transforms it into a patent-eligible application.

Q: How does the Leahy-Smith America Invents Act (AIA) impact patent litigation?

A: The AIA introduced several changes, including limiting the number of defendants in a lawsuit and the use of inter partes review (IPR) proceedings, which have affected the volume and characteristics of patent litigation.

Q: What is the purpose of the USPTO's Patent Claims Research Dataset?

A: The dataset provides detailed information on claims from U.S. patents and applications, allowing for the analysis of claim-level statistics and document-level statistics to understand patent scope and trends.

Q: Why is claim construction important in patent analysis?

A: Claim construction is critical because it determines the scope of what is covered by the patent, influencing its enforceability and validity.

Q: What is the proposed benefit of a small claims patent court?

A: A small claims patent court could simplify and reduce the costs associated with patent litigation, making it more accessible for smaller entities and inventors.

Sources

  1. GAO Report: Assessing Factors That Affect Patent Infringement Litigation, GAO-13-465.
  2. Federal Circuit Opinion: AI Visualize, Inc. v. Nuance Communications, Inc., 22-2109.
  3. USPTO Dataset: Patent Claims Research Dataset, USPTO.
  4. USPTO Search Tools: Search for patents, USPTO.
  5. ACUS Study: U.S. Patent Small Claims Court, ACUS.

More… ↓

⤷  Try for Free


Drugs Protected by US Patent 11,033,565

ApplicantTradenameGeneric NameDosageNDAApproval DateTETypeRLDRSPatent No.Patent ExpirationProductSubstanceDelist Req.Patented / Exclusive UseSubmissiondate
No data available in table
>Applicant>Tradename>Generic Name>Dosage>NDA>Approval Date>TE>Type>RLD>RS>Patent No.>Patent Expiration>Product>Substance>Delist Req.>Patented / Exclusive Use>Submissiondate
Showing 0 to 0 of 0 entries

Foreign Priority and PCT Information for Patent: 11,033,565

Foriegn Application Priority Data
Foreign Country Foreign Patent Number Foreign Patent Date
France0305048Apr 24, 2003

International Family Members for US Patent 11,033,565

CountryPatent NumberEstimated ExpirationSupplementary Protection CertificateSPC CountrySPC Expiration
European Patent Office 1620113 ⤷  Try for Free C300756 Netherlands ⤷  Try for Free
European Patent Office 1620113 ⤷  Try for Free CA 2015 00045 Denmark ⤷  Try for Free
European Patent Office 1620113 ⤷  Try for Free PA2015033 Lithuania ⤷  Try for Free
>Country>Patent Number>Estimated Expiration>Supplementary Protection Certificate>SPC Country>SPC Expiration
Showing 1 to 3 of 3 entries

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.